EUVIMEDEUVIMED entdecken
Crossref

Treatment of Pinguecula with Eye Drops of Dobesilate

Pedro Cuevas, Javier Angulo, Luis Outeiriño

Journal of Clinical Medical Research · 19.04.2026 · 7 (1) · 1-3

DOI: 10.46889/jcmr.2026.7119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medical Research, online erschienen am 19.04.2026. Verfasst von Pedro Cuevas und 2 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of fibroblast growth factor and vascular endothelial growth factor signalling pathways is effective in causing vessels regression in pinguecula. Regression of aberrant conjunctival vessels was documented 2 weeks after topical administration of ocular drops of dobesilate twice a day. At 2-months follow-up no recurrence nor ocular irritation were noted.

Zitieren

APA

Cuevas, P., Angulo, J., & Outeiriño, L. (2026). Treatment of Pinguecula with Eye Drops of Dobesilate. Journal of Clinical Medical Research, 7(1), 1-3. https://doi.org/10.46889/jcmr.2026.7119

Vancouver

Cuevas P, Angulo J, Outeiriño L. Treatment of Pinguecula with Eye Drops of Dobesilate. Journal of Clinical Medical Research. 2026;7(1):1-3. doi:10.46889/jcmr.2026.7119

BibTeX
@article{Cuevas2026,
  author = {Cuevas, Pedro and Angulo, Javier and Outeiriño, Luis},
  title = {Treatment of Pinguecula with Eye Drops of Dobesilate},
  journal = {Journal of Clinical Medical Research},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {1--3},
  doi = {10.46889/jcmr.2026.7119}
}
Kostenlos starten →